Octagenerian Population Undergoing Hip SurgeriesNCT05418374
Effects of Continuous Versus Single Dose Spinal Anesthesia in Octagenerians Undergoing Hip Surgery
A study testing Continous Spinal Anestheisa in people with Octagenerian Population Undergoing Hip Surgeries, run by Ain Shams University at 1 site in Egypt.
Trial summary
Continuous spinal anesthesia (CSA) is an anesthetic technique that offers several clinical advantages for anesthesia and analgesia in elderly patients. The level of sensory blockade can be titrated to the desired dermatomal level with great precision with intrathecal (IT) catheters, allowing better control of the… Read more about this study
- Who is it for?
- Ages 80 to 89 yearsHealthy volunteers can take part
- Conditions the study is for
- Octagenerian Population Undergoing Hip Surgeries
- What is being tested?
- Continous Spinal Anestheisa
- Type of treatment
- Injection or infusion, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Feb 2022to Aug 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 80 to 89 years
- All sexes
- Healthy volunteers accepted
- Older adult
Who may be able to join
- Either sex
- 80 to 89 years of age
- undergoing hip surgery
Who cannot join
- Patient refusal of procedure or participation in the study.
- Cardiac patients diagnosed with sever Aortic stenosis defined by echo as AVA (aortic valve area) < 1cm and MPG (mean pressure gradient ) >40mmHg.
- Patients with hemodynamic instability.
- Preexisting infection at the block site.
- Allergy to local anesthetics.
- Psychiatric illness.
- Increased intracranial tension.
- Patients with coagulopathy problems.
Trial locations and contacts
1 site in 1 country.
About this study
Continuous spinal anesthesia (CSA) is an anesthetic technique that offers several clinical advantages for anesthesia and analgesia in elderly patients. The level of sensory blockade can be titrated to the desired dermatomal level with great precision with intrathecal (IT) catheters, allowing better control of the hemodynamic consequences of sympathetic blockade associated with spinal anesthesia compared to epidural or single shot spinal techniques. Better control of hemodynamics maybe advantageous in patients with cardiac disease in whom administration of lower doses of local anesthetics is advantageous. Greater numbers of patients are presenting for surgery with aging-related pre-existing conditions, which places them at greater risk of an adverse outcome, such as cardiac or pulmonary disease or diabetes mellitus. CSA allows incremental dosing of an intrathecal local anesthetic providing fewer hemodynamic alterations. While spinal anesthesia is widely used anesthetic technique in lower limb surgery in the elderly, it induces more hemodynamic instability due to high blockage effect which largely limits the use of conventional dose of spinal anesthesia in high risk elderly patients
Read the detailed description
METHODOLOGY:
Patients and Method. Type of Study: Randomized controlled clinical trial. Approval will be obtained from the research ethics committee of Faculty of Medicine; Ain Shams University and a written informed consent will be taken from each patient to participate in the study. Study Setting: Ain-shams University Hospitals, Cairo, Egypt. Study Period: 6 months from approval of medical ethics committee. Sample Size: Based on the study of continuous spinal Anestheisa by Vincent M, Olivier F, and David G, 2006 assuming a rate of hypotension attacks (20% of the baseline blood pressure) of 15% in CSA group compared to 65% in SD spinal anesthesia group, a sample of 20 patients in each group is enough to detect such METHODOLOGY: Patients and Method. Type of Study: Randomized controlled clinical trial. Approval will be obtained from the research ethics committee of Faculty of Medicine; Ain Shams University and a written informed consent will be taken from each patient to participate in the study.METHODOLOGY:
Patients and Method. Type of Study: Randomized controlled clinical trial.
Study Setting: Ain-shams University Hospitals, Cairo, Egypt. Study Period: 6 months from approval of medical ethics committee. Sample Size: Based on the study of continuous spinal Anestheisa by Vincent M, Olivier F, and David G, 2006 (3) assuming a rate of hypotension attacks (20% of the baseline blood pressure) of 15% in CSA group compared to 65% in SD spinal anesthesia group, a sample of 20 patients in each group is enough to detect such difference, at 0.05 alpha error and 80% power of the test. Study tool: Visual Analogue Scale (VAS)
Study Procedures:
Based on this data, patients will be randomly allocated into two groups with 20 patients in each group.
- Preoperative settings:
All patients will be assessed preoperatively by careful history taking, full physical examination, and laboratory evaluation according to institutional guidelines, ECG and ECHO. A written consent will be taken after full description of the procedure. The Visual Analogue Score will be described properly to the patient before the procedure.
. Intraoperative settings: Patient will be allocated in one of the 2 study groups, Group A will receive continuous spinal anesthesia and Group B (control group) will receive traditional spinal anesthesia, All standard monitors will be placed (NIBP, pulse oximeter and electrocardiogram). All patients will receive oxygen (3 L/min) during the procedure, including the first postoperative hours. All patients will have an intravenous line (18G cannula), 500 ml Ringer will be started as a preload, airway and resuscitation equipment will be readily available. All equipment for the spinal blockade will be ready for use, and all necessary medications will be drawn up prior to positioning the patient for spinal anesthesia. Patients will receive 0.4 mg/kg propofol IV 3 min before being turned to the lateral position for lumbar puncture. The patient will be positioned in lateral position with the injured leg up. The ideal positioning consists of having the back of the patient parallel to the edge of the bed closest to the anesthesiologist, with the patient's knees flexed to the abdomen and neck flexed, the midline will be palpated. The iliac crests will be palpated, and a line is drawn between them to find the body of L4 or the L4-L5 interspace. All techniques will be done under complete aseptic condition using Betadine 5%. A small wheal of local anesthetic (lidocaine 0.5%) is injected into the skin at the planned site of insertion. In study group (A), 18G epidural needle will be inserted intrathecally at the level of L4-L5. After insertion of the Tuohy needle, the subarachnoid space is found and the bevel is directed downward, and the spinal catheter is passed 2-3 cm into the subarachnoid space. After confirmation of aspiration cerebral spinal fluid through the catheter, an initial dose 2.5 mg (0.5 ml) of plain bupivacaine 0.5%(manufactured by sunny medical ) will be injected. After assessment of systemic blood pressure and sensory level, After completion of injection the patients remained in the lateral position for 5 min and then will be returned to the supine position, increments of 2.5 mg (0.5 ml) of the same solution will be given every 15 minutes until reaching the required anesthetic level of T10. In case of failure or insufficient block, general anesthesia will be performed. In control group traditional spinal anesthesia will be done with a 25G pencil point spinal needle at the level of L4-L5 with injection of 12.5 mg (2.5ml) of bupivacaine 0.5%. By adjusting the head level, T10 sensory block will be targeted. In both groups, patients will be positioned for surgery after achieving sensory blockage of T10 level. Testing the sensory level will be done using The ice pack method: by Placing an ice on an area well away from the possible dermatome cover (eg face or forearm) and ask them to tell you how cold it feels to them then Apply the ice to an area likely to be blocked on the same side of the body and ask the patient "Does this feel the same cold as your face/arm or different?" Patients may report the ice feeling colder, warmer or the same, Apply the ice to areas above and below this point until it's clear at which level the top and the bottom of the block is and repeat the procedure on the opposite side of the body continuous close monitoring of vital data and complications of spinal anesthesia will be recorded till the end of the surgery, Noninvasive automated arterial blood pressure, heart rate measurements and saturation will be recorded before the spinal anesthesia (baseline), vital data will be monitored 3 minutes after the spinal anesthesia, every 5 minutes in the first 15 minutes after spinal anesthesia, and every 15 min thereafter.
- Hypotension defined as a decrease in Blood pressure (20% from the baseline), will be treated with IV boluses of ephedrine 6 mg repeated every 3 min.
- Bradycardia defined as decrease in the heart rate (20% from the baseline) and Will be treated with atropine 1 mg.
- Desaturation defined as decrease in saturation less than 94% and will be managed by oxygen mask .
- Postoperative settings:
Monitoring vitals for 12 hours postoperatively for any possible complications every 10 minutes in the PACU and every 30 mins after discharge to the ward unit.
Measurements:
- Mean arterial Blood pressure (Hypotension defined as decrease in blood pressure 20% from the baseline) will be managed with 6 mg bolus of ephidrine.
- Heart rate (Bradycardia defined as decrease in heart rate 20% from the baseline ) will be managed with atropine 1mg .
- Oxygen saturation (Desaturation defined as decrease in saturation below 94%) will be managed with oxygen mask.
- Incidence complications e.g
- Nausea and vomiting ( can be managed using metoclopramide).
- Hypotension ( 6 mg bolus ephedrine will be given).
- shivering (pethidine 25 mg can be given also dexamethasone 8 mg has an effect in reducing the post spinal shivering)
- Post dural puncture headache (will be managed by bed rest, IV hydration, caffeine supplementation and analgesics.
- Spinal hematoma ( will be managed by immediate surgical drainage, vitamin k1 2.5- 10mg and fresh frozen plasma .
- Total spinal (will be managed by oxygen delivery and intubation).
Statistical Analysis:
● Statistical Package: All data will be analyzed statistically. All data will be included in the SPSS software version 21. The appropriate statistical method will be used for analysis. Descriptive statistics such as mean, standard deviation and percentages will be used. Comparison of categorical data will be done using Chi-square test and for continuous data; unpaired "t" test will be used.
- Being tested
- Continous Spinal Anestheisa
- Keywords
- Octagenerians, Hip surgery, Spinal anesthesia, Continuous spinal anesthesia, Visual Analogue Scale
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Continous Spinal AnestheisaProcedure or surgery
Continuous spinal anesthesia (CSA) describes subarachnoid blockade maintained by local anesthetics administered through an indwelling spinal catheter. CSA provides fewer episodes of hypotension and no severe hypotension versus single dose bupivacaine also it offers the ability to titrate the dose of local anesthetics needed while maintaining hemodynamic stability.
| Study group | Role | What they receive |
|---|---|---|
| Group A | Active comparator | 18G epidural needle will be inserted intrathecally at the level of L4-L5. After insertion of the Tuohy needle, the subarachnoid space is found and the bevel is directed downward, and the spinal catheter is passed 2-3 cm into the subarachnoid space. After confirmation of aspiration cerebral spinal fluid through the catheter, an initial dose 2.5 mg (0.5 ml) of plain bupivacaine 0.5%(manufactured by sunny medical ) will be injected. Receives: Procedure: Continous Spinal Anestheisa |
| Control group | No intervention | traditional spinal anesthesia will be done with a 25G pencil point spinal needle at the level of L4-L5 with injection of 12.5 mg (2.5ml) of bupivacaine 0.5%. By adjusting the head level, T10 sensory block will be targeted |
What is being measured
The primary outcome is the main question the study is designed to answer.
Incidence of hypotension
to compare the The incidence of hypotension (defined as decrease in blood pressure 20% from the base line) in continuous spinal anesthesia CSA versus single dose spinal anesthesia in octogenarians undergoing hip surgery
Measured: Intraoperative and up to 12 hours postoperative
Secondary outcomes (2)
Total use of vasopressor
to determine the total use of vasopressor (Ephedrine) in each group
Measured: Intraoperative
Spinal anesthesia complications
the incidence of spinal complications as nausea, vomiting and post dural puncture headache
Measured: Intraoperative and up to 12 hours postoperative
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jun 2022
- Study start1 Feb 2022
- Primary completionAug 2022 (estimated)
- Study completionAug 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Octagenerian Population Undergoing Hip SurgeriesStudies of the same condition, open and under way.
- More trials run by Ain Shams UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ain Shams University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Hany M. Elzahaby, M.D., Study director, AinShams University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05418374
- Sponsor's protocol ID
- FMASU 54/2022
- Status last verified
- Jun 2022
- First submitted
- 10 Jun 2022
- Last updated
- 14 Jun 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: all IPD that underlie results in a publication
Publications
Favarel-Garrigues JF, Sztark F, Petitjean ME, Thicoipe M, Lassie P, Dabadie P. Hemodynamic effects of spinal anesthesia in the elderly: single dose versus titration through a catheter. Anesth Analg. 1996 Feb;82(2):312-6. doi: 10.1097/00000539-199602000-00017.
PubMed 8561333De Andres JA, Febre E, Bellver J, Bolinches R. Continuous spinal anaesthesia versus single dosing. A comparative study. Eur J Anaesthesiol. 1995 Mar;12(2):135-40.
PubMed 7781632
Study at a glance
From the registry record, last updated by the sponsor on 14 Jun 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Continuous Versus Single Dose Spinal Anesthesia in Octagenerians Undergoing Hip Surgery
- ClinicalTrials.gov ID
- NCT05418374
- Acronym / sponsor ID
- FMASU 54/2022
- Keywords
- Octagenerians, Hip surgery, Spinal anesthesia, Continuous spinal anesthesia, Visual Analogue Scale
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Ain Shams UniversityUniversity, hospital or other
- Study start
- 1 Feb 2022 (actual)
- Primary completion
- Aug 2022 (estimated)
- Study completion
- Aug 2022 (estimated)
- First posted
- 14 Jun 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Continuous spinal anesthesia (CSA) is an anesthetic technique that offers several clinical advantages for anesthesia and analgesia in elderly patients. The level of sensory blockade can be titrated to the desired dermatomal level with great precision with intrathecal (IT) catheters, allowing better control of the hemodynamic consequences of sympathetic blockade associated with spinal anesthesia compared to epidural or single shot spinal techniques. Better control of hemodynamics maybe advantageous in patients with cardiac disease in whom administration of lower doses of local anesthetics is advantageous. Greater numbers of patients are presenting for surgery with aging-related pre-existing conditions, which places them at greater risk of an adverse outcome, such as cardiac or pulmonary disease or diabetes mellitus. CSA allows incremental dosing of an intrathecal local anesthetic providing fewer hemodynamic alterations. While spinal anesthesia is widely used anesthetic technique in lower limb surgery in the elderly, it induces more hemodynamic instability due to high blockage effect which largely limits the use of conventional dose of spinal anesthesia in high risk elderly patients
Detailed description
METHODOLOGY:
Patients and Method. Type of Study: Randomized controlled clinical trial. Approval will be obtained from the research ethics committee of Faculty of Medicine; Ain Shams University and a written informed consent will be taken from each patient to participate in the study. Study Setting: Ain-shams University Hospitals, Cairo, Egypt. Study Period: 6 months from approval of medical ethics committee. Sample Size: Based on the study of continuous spinal Anestheisa by Vincent M, Olivier F, and David G, 2006 assuming a rate of hypotension attacks (20% of the baseline blood pressure) of 15% in CSA group compared to 65% in SD spinal anesthesia group, a sample of 20 patients in each group is enough to detect such METHODOLOGY: Patients and Method. Type of Study: Randomized controlled clinical trial. Approval will be obtained from the research ethics committee of Faculty of Medicine; Ain Shams University and a written informed consent will be taken from each patient to participate in the study.METHODOLOGY:
Patients and Method. Type of Study: Randomized controlled clinical trial.
Study Setting: Ain-shams University Hospitals, Cairo, Egypt. Study Period: 6 months from approval of medical ethics committee. Sample Size: Based on the study of continuous spinal Anestheisa by Vincent M, Olivier F, and David G, 2006 (3) assuming a rate of hypotension attacks (20% of the baseline blood pressure) of 15% in CSA group compared to 65% in SD spinal anesthesia group, a sample of 20 patients in each group is enough to detect such difference, at 0.05 alpha error and 80% power of the test. Study tool: Visual Analogue Scale (VAS)
Study Procedures:
Based on this data, patients will be randomly allocated into two groups with 20 patients in each group.
- Preoperative settings:
All patients will be assessed preoperatively by careful history taking, full physical examination, and laboratory evaluation according to institutional guidelines, ECG and ECHO. A written consent will be taken after full description of the procedure. The Visual Analogue Score will be described properly to the patient before the procedure.
. Intraoperative settings: Patient will be allocated in one of the 2 study groups, Group A will receive continuous spinal anesthesia and Group B (control group) will receive traditional spinal anesthesia, All standard monitors will be placed (NIBP, pulse oximeter and electrocardiogram). All patients will receive oxygen (3 L/min) during the procedure, including the first postoperative hours. All patients will have an intravenous line (18G cannula), 500 ml Ringer will be started as a preload, airway and resuscitation equipment will be readily available. All equipment for the spinal blockade will be ready for use, and all necessary medications will be drawn up prior to positioning the patient for spinal anesthesia. Patients will receive 0.4 mg/kg propofol IV 3 min before being turned to the lateral position for lumbar puncture. The patient will be positioned in lateral position with the injured leg up. The ideal positioning consists of having the back of the patient parallel to the edge of the bed closest to the anesthesiologist, with the patient's knees flexed to the abdomen and neck flexed, the midline will be palpated. The iliac crests will be palpated, and a line is drawn between them to find the body of L4 or the L4-L5 interspace. All techniques will be done under complete aseptic condition using Betadine 5%. A small wheal of local anesthetic (lidocaine 0.5%) is injected into the skin at the planned site of insertion. In study group (A), 18G epidural needle will be inserted intrathecally at the level of L4-L5. After insertion of the Tuohy needle, the subarachnoid space is found and the bevel is directed downward, and the spinal catheter is passed 2-3 cm into the subarachnoid space. After confirmation of aspiration cerebral spinal fluid through the catheter, an initial dose 2.5 mg (0.5 ml) of plain bupivacaine 0.5%(manufactured by sunny medical ) will be injected. After assessment of systemic blood pressure and sensory level, After completion of injection the patients remained in the lateral position for 5 min and then will be returned to the supine position, increments of 2.5 mg (0.5 ml) of the same solution will be given every 15 minutes until reaching the required anesthetic level of T10. In case of failure or insufficient block, general anesthesia will be performed. In control group traditional spinal anesthesia will be done with a 25G pencil point spinal needle at the level of L4-L5 with injection of 12.5 mg (2.5ml) of bupivacaine 0.5%. By adjusting the head level, T10 sensory block will be targeted. In both groups, patients will be positioned for surgery after achieving sensory blockage of T10 level. Testing the sensory level will be done using The ice pack method: by Placing an ice on an area well away from the possible dermatome cover (eg face or forearm) and ask them to tell you how cold it feels to them then Apply the ice to an area likely to be blocked on the same side of the body and ask the patient "Does this feel the same cold as your face/arm or different?" Patients may report the ice feeling colder, warmer or the same, Apply the ice to areas above and below this point until it's clear at which level the top and the bottom of the block is and repeat the procedure on the opposite side of the body continuous close monitoring of vital data and complications of spinal anesthesia will be recorded till the end of the surgery, Noninvasive automated arterial blood pressure, heart rate measurements and saturation will be recorded before the spinal anesthesia (baseline), vital data will be monitored 3 minutes after the spinal anesthesia, every 5 minutes in the first 15 minutes after spinal anesthesia, and every 15 min thereafter.
- Hypotension defined as a decrease in Blood pressure (20% from the baseline), will be treated with IV boluses of ephedrine 6 mg repeated every 3 min.
- Bradycardia defined as decrease in the heart rate (20% from the baseline) and Will be treated with atropine 1 mg.
- Desaturation defined as decrease in saturation less than 94% and will be managed by oxygen mask .
- Postoperative settings:
Monitoring vitals for 12 hours postoperatively for any possible complications every 10 minutes in the PACU and every 30 mins after discharge to the ward unit.
Measurements:
- Mean arterial Blood pressure (Hypotension defined as decrease in blood pressure 20% from the baseline) will be managed with 6 mg bolus of ephidrine.
- Heart rate (Bradycardia defined as decrease in heart rate 20% from the baseline ) will be managed with atropine 1mg .
- Oxygen saturation (Desaturation defined as decrease in saturation below 94%) will be managed with oxygen mask.
- Incidence complications e.g
- Nausea and vomiting ( can be managed using metoclopramide).
- Hypotension ( 6 mg bolus ephedrine will be given).
- shivering (pethidine 25 mg can be given also dexamethasone 8 mg has an effect in reducing the post spinal shivering)
- Post dural puncture headache (will be managed by bed rest, IV hydration, caffeine supplementation and analgesics.
- Spinal hematoma ( will be managed by immediate surgical drainage, vitamin k1 2.5- 10mg and fresh frozen plasma .
- Total spinal (will be managed by oxygen delivery and intubation).
Statistical Analysis:
● Statistical Package: All data will be analyzed statistically. All data will be included in the SPSS software version 21. The appropriate statistical method will be used for analysis. Descriptive statistics such as mean, standard deviation and percentages will be used. Comparison of categorical data will be done using Chi-square test and for continuous data; unpaired "t" test will be used.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group A | Active comparator | Procedure: Continous Spinal Anestheisa18G epidural needle will be inserted intrathecally at the level of L4-L5. After insertion of the Tuohy needle, the subarachnoid space is found and the bevel is directed downward, and the spinal catheter is passed 2-3 cm into the subarachnoid space. After confirmation of aspiration cerebral spinal fluid through the catheter, an initial dose 2.5 mg (0.5 ml) of plain bupivacaine 0.5%(manufactured by sunny medical ) will be injected. |
| Control group | No intervention | –traditional spinal anesthesia will be done with a 25G pencil point spinal needle at the level of L4-L5 with injection of 12.5 mg (2.5ml) of bupivacaine 0.5%. By adjusting the head level, T10 sensory block will be targeted |
Who may qualify
- Ages
- 80 to 89 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
Key inclusion criteria (3 listed)
- Either sex
- 80 to 89 years of age
- undergoing hip surgery
Key exclusion criteria (8 listed)
- Patient refusal of procedure or participation in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Continous Spinal AnestheisaContinuous spinal anesthesia (CSA) describes subarachnoid blockade maintained by local anesthetics administered through an indwelling spinal catheter. CSA provides fewer episodes of hypotension and no severe hypotension versus single dose bupivacaine also it offers the ability to titrate the dose of local anesthetics needed while maintaining hemodynamic stability. | Procedure or surgery | Group A |
Primary outcome
Incidence of hypotension
Time frame: Intraoperative and up to 12 hours postoperative
to compare the The incidence of hypotension (defined as decrease in blood pressure 20% from the base line) in continuous spinal anesthesia CSA versus single dose spinal anesthesia in octogenarians undergoing hip surgery
2 secondary outcomes
Total use of vasopressor
Time frame: Intraoperative
Spinal anesthesia complications
Time frame: Intraoperative and up to 12 hours postoperative
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Jun 2022.
- Background: PubMed 8561333Favarel-Garrigues JF, Sztark F, Petitjean ME, Thicoipe M, Lassie P, Dabadie P. Hemodynamic effects of spinal anesthesia in the elderly: single dose versus titration through a catheter. Anesth Analg. 1996 Feb;82(2):312-6. doi: 10.1097/00000539-199602000-00017.
- Background: PubMed 7781632De Andres JA, Febre E, Bellver J, Bolinches R. Continuous spinal anaesthesia versus single dosing. A comparative study. Eur J Anaesthesiol. 1995 Mar;12(2):135-40.
- Individual participant dataSharing planned: Yes. all IPD that underlie results in a publication
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hany M. Elzahaby, M.D. study director
AinShams University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Continous Spinal Anestheisa in people with Octagenerian Population Undergoing Hip Surgeries, run by Ain Shams University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 14 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Aya H. Moussa, M.D. (+201114555939, Ayahisham@med.asu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Incidence of hypotension (time frame: Intraoperative and up to 12 hours postoperative). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05418374, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jun 2022.